Your selections:
The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer
- Biswas, Tithi, Efird, Jimmy T., Prasad, Shreya, Jindal, Charulata, Walker, Paul R.
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
- Wagner, U., Marth, C., Gebski, V., Lauraine, E. P., Largillier, R., Kaern, J., Brown, C., Heywood, M., Bonaventura, T., Vergote, I., Piccirillo, M. C., Fossati, R.
Are you sure you would like to clear your session, including search history and login status?